ADC Therapeutics grants $2.9M cash and 1.1M RSU retention awards to CEO, CFO, CMO

ADC Therapeutics SA

CEO Ameet Mallik receives $1,795,500 cash and 675,000 RSUs; CFO Jose Carmona $541,842 cash and 203,700 RSUs; CMO Mohamed Zaki $568,974 cash and 213,900 RSUs.
Cash awards payable July 15, 2026; subject to repayment if employment ends before June 30, 2027 (exceptions for termination without cause or for good reason).
RSUs vest on June 30, 2027 or earlier upon termination without cause or for good reason, subject to continued employment.
Awards approved by Board with advice of independent compensation consultant on June 30, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.